Novartis Exjade Review Complicated By Use Of SQUID To Measure Iron Levels
This article was originally published in Pharmaceutical Approvals Monthly
Executive Summary
Use of a superconducting quantum interference device (SQUID) is "inadequate" to accurately measure liver iron concentration, FDA determined in its review of Novartis’ oral iron chelating agent Exjade.